Yinghua Zhao, Liyan Sui, Ping Wu, Letian Li, Li Liu, Baohua Ma, Wenfang Wang, Hongmiao Chi, Ze-Dong Wang, Zhengkai Wei, Zhijun Hou, Kaiyu Zhang, Junqi Niu, Ningyi Jin, Chang Li, Jixue Zhao, Guoqing Wang, Quan Liu
Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to an unprecedented public health crisis worldwide. Though the host produces interferons (IFNs) and restriction factors to suppress virus infection, SARS-CoV-2 has evolved multiple strategies to inhibit the antiviral responses. Understanding host restriction factors and viral escape mechanisms is conducive to developing effective anti-SARS-CoV-2 drugs. Here, we constructed SARS-CoV-2 nucleocapsid (2N) protein- and green fluorescent protein (GFP)-stably expressing cells that were transfected with polyinosinic-polycytidylic acid (poly(I:C)) to activate IFN responses...
September 29, 2023: Journal of Virology